An Automated High-Throughput Cell-Based Multiplexed Flow Cytometry Assay to Identify Novel Compounds to Target Candida albicans Virulence-Related Proteins
Open Access
- 28 October 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (10) , e110354
Abstract
Although three major classes of systemic antifungal agents are clinically available, each is characterized by important limitations. Thus, there has been considerable ongoing effort to develop novel and repurposed agents for the therapy of invasive fungal infections. In an effort to address these needs, we developed a novel high-throughput, multiplexed screening method that utilizes small molecules to probe candidate drug targets in the opportunistic fungal pathogen Candida albicans. This method is amenable to high-throughput automated screening and is based upon detection of changes in GFP levels of individually tagged target proteins. We first selected four GFP-tagged membrane-bound proteins associated with virulence or antifungal drug resistance in C. albicans. We demonstrated proof-of-principle that modulation of fluorescence intensity can be used to assay the expression of specific GFP-tagged target proteins to inhibitors (and inducers), and this change is measurable within the HyperCyt automated flow cytometry sampling system. Next, we generated a multiplex of differentially color-coded C. albicans strains bearing C-terminal GFP-tags of each gene encoding candidate drug targets incubated in the presence of small molecules from the Prestwick Chemical Library in 384-well microtiter plate format. Following incubation, cells were sampled through the HyperCyt system and modulation of protein levels, as indicated by changes in GFP-levels of each strain, was used to identify compounds of interest. The hit rate for both inducers and inhibitors identified in the primary screen did not exceed 1% of the total number of compounds in the small-molecule library that was probed, as would be expected from a robust target-specific, high-throughput screening campaign. Secondary assays for virulence characteristics based on null mutant strains were then used to further validate specificity. In all, this study presents a method for the identification and verification of new antifungal drugs targeted to fungal virulence proteins using C. albicans as a model fungal pathogen.Keywords
This publication has 49 references indexed in Scilit:
- Identification of a Small Molecule Yeast TORC1 Inhibitor with a Multiplex Screen Based on Flow CytometryACS Chemical Biology, 2012
- Modulation of Morphogenesis in Candida albicans by Various Small MoleculesEukaryotic Cell, 2011
- Cell-Based Screening Using High-Throughput Flow CytometryASSAY and Drug Development Technologies, 2011
- Emerging opportunistic yeast infectionsThe Lancet Infectious Diseases, 2011
- The Sur7 Protein Regulates Plasma Membrane Organization and Prevents Intracellular Cell Wall Growth inCandida albicansMolecular Biology of the Cell, 2008
- Pyrosequencing To Detect Mutations in FKS1 That Confer Reduced Echinocandin Susceptibility in Candida albicansAntimicrobial Agents and Chemotherapy, 2008
- ABC Transporter Cdr1p Contributes More than Cdr2p Does to Fluconazole Efflux in Fluconazole-Resistant Candida albicans Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2008
- Inhibition of Filamentation Can Be Used To Treat Disseminated CandidiasisAntimicrobial Agents and Chemotherapy, 2006
- Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profilingNature Methods, 2006
- Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. IsolatesAntimicrobial Agents and Chemotherapy, 2005